The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

December 15, 2016 • By Charles Radis, DO

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In 1998, under yet another reorganization plan by Dow Corning to emerge from bankruptcy, women who wanted to cash out immediately and not file a disease claim were promised $2,000. For those who had previously filed a disease claim, between $10,000 and $250,000 was to be awarded, a far cry from the millions promised in the original settlement.

You Might Also Like
  • Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
  • Somatic Mosaicism Can Complicate Diagnosis of Autoimmune Disease
  • When Symptoms of Rheumatic Disorder Point to Endocrine Disease
Explore This Issue
December 2016
Also By This Author
  • Diagnosis Can Be Elusive for Fever of Unknown Origin

From time to time, I would see women who had signed up for the settlement but needed a local rheumatologist to manage their symptoms. And I gradually began to better understand the powerful psychodynamics that prevented them from recovering.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Over time, they became patients as opposed to litigants. Several improved—to some degree—by having the silicone breast implants removed; others did not. I neither encouraged them to take, nor discouraged them from taking, this step; I just couldn’t predict if it would help.

Medication trials were largely ineffective; muscle relaxants helped to some degree with insomnia and muscle tension, and many patients were prescribed combinations of anti-anxiety and anti-depression meds by their primary care providers, again, with mixed results.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For the most part, my subset of silicone breast implant sufferers remained unwell. Diffuse pain and stiffness and depression were their constant companions.

My Understanding

One woman in particular, who I followed for the better part of four years, helped me understand the mystery of why silicone breast implant sufferers were more functionally impaired than my worst rheumatoid patients. The answer, I believe, goes to the heart and mind of who the breast implant patients were before they underwent breast augmentation.

Milly T. just wanted to feel better. She’d been evaluated by two previous rheumatologists, and both agreed that she didn’t have a connective tissue disorder. Instead, they diagnosed her with fibromyalgia syndrome, a diffuse pain syndrome associated with non-restorative, fragmented sleep, often accompanied by depression and anxiety. And for the most part she accepted the diagnosis. But near the conclusion of our initial visit, I noticed in her patient questionnaire that her mother had died at age 34 and asked her what happened.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Murdered,” she said simply.

“And you were how old? 12?”

“Yes.”

“And your sisters?”

“7, 10, l4.”

“Well, I’m sorry. Do you want to tell me what happened?”

“No. … Well, she was killed at home. It was a robbery, and he … he …well, he shot her in front of us.”

I closed my eyes, the image of that awful blistering moment filling my mind.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Autoimmune disease, breast implant, Diagnosis, Lupus, patient care, physician, rheumatologist, silicone, SLE, symptomIssue: December 2016

You Might Also Like:
  • Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
  • Somatic Mosaicism Can Complicate Diagnosis of Autoimmune Disease
  • When Symptoms of Rheumatic Disorder Point to Endocrine Disease
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.